Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Impact on antitumor response using a new adjuvant preparation as a component of a human papillomavirus type 16 therapeutic vaccine candidate.

Granadillo M, Batte A, Alfonso AB, Blanco A, Urquiza D, Varas L, Soler D, Miyares M, Limonta M, Torrens I.

Vaccine. 2019 Jul 9;37(30):3957-3960. doi: 10.1016/j.vaccine.2019.05.060. Epub 2019 May 30.

PMID:
31155419
2.

Novel Curcumin Inspired Bis-Chalcone Promotes Endoplasmic Reticulum Stress and Glioblastoma Neurosphere Cell Death.

Sansalone L, Veliz EA, Myrthil NG, Stathias V, Walters W, Torrens II, Schürer SC, Vanni S, Leblanc RM, Graham RM.

Cancers (Basel). 2019 Mar 13;11(3). pii: E357. doi: 10.3390/cancers11030357.

3.

[Prevalence of insomnia and characteristic of patients with insomnia in a health area of Majorca (Spain)].

Torrens I, Argüelles-Vázquez R, Lorente-Montalvo P, Molero-Alfonso C, Esteva M.

Aten Primaria. 2019 Mar 8. pii: S0212-6567(17)30307-4. doi: 10.1016/j.aprim.2018.02.014. [Epub ahead of print] Spanish.

4.

Expression optimization of a cell membrane-penetrating human papillomavirus type 16 therapeutic vaccine candidate in Nicotiana benthamiana.

Yanez RJR, Lamprecht R, Granadillo M, Weber B, Torrens I, Rybicki EP, Hitzeroth II.

PLoS One. 2017 Aug 11;12(8):e0183177. doi: 10.1371/journal.pone.0183177. eCollection 2017.

5.

LALF32-51 -E7, a HPV-16 therapeutic vaccine candidate, forms protein body-like structures when expressed in Nicotiana benthamiana leaves.

Yanez RJR, Lamprecht R, Granadillo M, Torrens I, Arcalís E, Stöger E, Rybicki EP, Hitzeroth II.

Plant Biotechnol J. 2018 Feb;16(2):628-637. doi: 10.1111/pbi.12802. Epub 2017 Sep 7.

6.

LALF32-51-E7 therapeutic vaccine induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the lungs.

Granadillo M, Batte A, Blanco A, Alfonso AB, Suárez J, Merino N, Carballo R, González BO, Prieto YC, Varas L, Soler D, Limonta M, Miyares M, Aldana L, Torrens I.

Clin Exp Metastasis. 2017 Apr;34(3-4):241-249. doi: 10.1007/s10585-017-9846-x. Epub 2017 Apr 17.

PMID:
28417212
7.

Knowledge and attitudes of primary care nurses about the management of patients with insomnia.

Vidal-Thomàs MC, Yañez-Amoros B, Torrens I, Torres-Solera E, Esteva M.

Enferm Clin. 2017 May - Jun;27(3):186-192. doi: 10.1016/j.enfcli.2016.11.006. Epub 2017 Jan 6. English, Spanish.

PMID:
28089108
8.

[Attitudes to insomnia by Primary Care physicians of Majorca (Spain)].

Torrens I, Ortuño M, Guerra JI, Esteva M, Lorente P.

Aten Primaria. 2016 Jun-Jul;48(6):374-82. doi: 10.1016/j.aprim.2015.06.012. Epub 2015 Nov 2. Spanish.

9.

Expression, purification and characterization of a recombinant fusion protein based on the human papillomavirus-16 E7 antigen.

Granadillo M, Batte A, Lugo VM, Musacchio A, Bequet-Romero M, Betancourt L, Besada V, Javier L, Molina R, Falcón V, Torrens I.

Springerplus. 2013 Dec;2(1):12. doi: 10.1186/2193-1801-2-12. Epub 2013 Jan 12.

10.

Safety and Immunogenicity of a Human Papillomavirus Peptide Vaccine (CIGB-228) in Women with High-Grade Cervical Intraepithelial Neoplasia: First-in-Human, Proof-of-Concept Trial.

Solares AM, Baladron I, Ramos T, Valenzuela C, Borbon Z, Fanjull S, Gonzalez L, Castillo D, Esmir J, Granadillo M, Batte A, Cintado A, Ale M, Fernandez de Cossio ME, Ferrer A, Torrens I, Lopez-Saura P.

ISRN Obstet Gynecol. 2011;2011:292951. doi: 10.5402/2011/292951. Epub 2011 Mar 24.

11.

A novel fusion protein-based vaccine comprising a cell penetrating and immunostimulatory peptide linked to human papillomavirus (HPV) type 16 E7 antigen generates potent immunologic and anti-tumor responses in mice.

Granadillo M, Vallespi MG, Batte A, Mendoza O, Soria Y, Lugo VM, Torrens I.

Vaccine. 2011 Jan 29;29(5):920-30. doi: 10.1016/j.vaccine.2010.11.083. Epub 2010 Dec 9.

PMID:
21145912
12.

Identification of a novel antitumor peptide based on the screening of an Ala-library derived from the LALF(32-51) region.

Vallespi MG, Fernandez JR, Torrens I, Garcia I, Garay H, Mendoza O, Granadillo M, Falcon V, Acevedo B, Ubieta R, Guillen GE, Reyes O.

J Pept Sci. 2010 Jan;16(1):40-7. doi: 10.1002/psc.1192.

PMID:
19908203
13.

Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice.

Bequet-Romero M, Ayala M, Acevedo BE, Rodríguez EG, Ocejo OL, Torrens I, Gavilondo JV.

Angiogenesis. 2007;10(1):23-34. Epub 2007 Feb 2.

PMID:
17273909
14.

Immunotherapy with CTL peptide and VSSP eradicated established human papillomavirus (HPV) type 16 E7-expressing tumors.

Torréns I, Mendoza O, Batte A, Reyes O, Fernández LE, Mesa C, Guillén G.

Vaccine. 2005 Dec 30;23(50):5768-74. Epub 2005 Aug 8.

PMID:
16112257
15.

Antitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2).

Perea SE, Reyes O, Puchades Y, Mendoza O, Vispo NS, Torrens I, Santos A, Silva R, Acevedo B, López E, Falcón V, Alonso DF.

Cancer Res. 2004 Oct 1;64(19):7127-9.

16.

Profiling the immune responses of human patients treated with recombinant streptokinase after myocardial infarct.

Reyes O, Torrens I, Ojalvo AG, Seralena A, Garay HE.

Mol Divers. 2004;8(3):251-6.

PMID:
15384418
17.

A mutant streptokinase lacking the C-terminal 42 amino acids is less immunogenic.

Torrèns I, Ojalvo AG, Seralena A, Hayes O, de la Fuente J.

Immunol Lett. 1999 Dec 1;70(3):213-8.

PMID:
10656677
18.

A mutant streptokinase lacking the C-terminal 42 amino acids is less reactive with preexisting antibodies in patient sera.

Torréns I, Ojalvo AG, Seralena A, Pupo E, Lugo V, Páez R.

Biochem Biophys Res Commun. 1999 Dec 9;266(1):230-6.

PMID:
10581194
19.

Prevalence of circulating antibodies against a streptokinase C-terminal peptide in normal blood donors.

Ojalvo AG, Pozo L, Labarta V, Torréns I.

Biochem Biophys Res Commun. 1999 Sep 24;263(2):454-9.

PMID:
10491315
20.

Mapping of the antigenic regions of streptokinase in humans after streptokinase therapy.

Torréns I, Reyes O, Ojalvo AG, Seralena A, Chinea G, Cruz LJ, de la Fuente J.

Biochem Biophys Res Commun. 1999 May 27;259(1):162-8.

PMID:
10334933
21.

Hipersensitivity to fruits in latex allergic patients.

Monreal P, Server MT, Torrens I, Soler Escoda JM.

Allergol Immunopathol (Madr). 1996 Jan-Feb;24(1):33-5.

PMID:
8882760
22.

Localization of the candidate gene D-amino acid oxidase outside the refined I-cM region of spinocerebellar ataxia 2.

Gispert S, Lunkes A, Santos N, Orozco G, Ha-Hao D, Ratzlaff T, Aguiar J, Torrens I, Heredero L, Brice A, et al.

Am J Hum Genet. 1995 Oct;57(4):972-5. No abstract available.

23.

Home nursing care for veterans.

ADDAMS R, TORRENS IF.

Nurs Outlook. 1956 Sep;4(9):497-9. No abstract available.

PMID:
13369912
24.

The VA community nursing program.

ADDAMS R, TORRENS I.

Public Health Nurs. 1951 Sep;43(9):509; passim. No abstract available.

PMID:
14875842

Supplemental Content

Loading ...
Support Center